Braze, Inc.
Braze, Inc. (BRZE) Financial Performance & Income Statement Overview
Review Braze, Inc. (BRZE) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Braze, Inc. (BRZE) Income Statement & Financial Overview
View the income breakdown for Braze, Inc. BRZE across both annual and quarterly reports.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $160.40M | $152.05M | $145.50M | $135.46M |
| Cost of Revenue | $49.31M | $45.91M | $43.42M | $44.55M |
| Gross Profit | $111.09M | $106.14M | $102.08M | $90.91M |
| Gross Profit Ratio | $0.69 | $0.70 | $0.70 | $0.67 |
| R&D Expenses | $33.60M | $32.85M | $33.14M | $34.37M |
| SG&A Expenses | $99.05M | $105.86M | $96.89M | $96.62M |
| Operating Expenses | $132.65M | $138.71M | $130.03M | $130.99M |
| Total Costs & Expenses | $181.96M | $184.62M | $173.45M | $175.54M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.75M | $2.64M | $2.61M | $2.20M |
| EBITDA | -$18.81M | -$29.93M | -$25.34M | -$38.79M |
| EBITDA Ratio | -$0.12 | -$0.20 | -$0.17 | -$0.29 |
| Operating Income | -$21.56M | -$32.57M | -$27.95M | -$40.08M |
| Operating Income Ratio | -$0.13 | -$0.21 | -$0.19 | -$0.30 |
| Other Income/Expenses (Net) | $5.59M | $5.29M | $5.50M | $5.17M |
| Income Before Tax | -$15.97M | -$27.28M | -$22.45M | -$34.91M |
| Income Before Tax Ratio | -$0.10 | -$0.18 | -$0.15 | -$0.26 |
| Income Tax Expense | $1.09M | $851000.00 | $702000.00 | $798000.00 |
| Net Income | -$17.19M | -$27.91M | -$23.00M | -$35.64M |
| Net Income Ratio | -$0.11 | -$0.18 | -$0.16 | -$0.26 |
| EPS | -$0.17 | -$0.27 | -$0.23 | -$0.35 |
| Diluted EPS | -$0.17 | -$0.27 | -$0.23 | -$0.35 |
| Weighted Avg Shares Outstanding | $102.92M | $102.15M | $101.45M | $100.79M |
| Weighted Avg Shares Outstanding (Diluted) | $102.92M | $102.15M | $101.45M | $100.79M |
The company's financials show resilient growth, with revenue advancing from $135.46M in Q1 2025 to $160.40M in Q4 2025. Gross profit remained healthy with margins at 69% in Q4 2025 compared to 67% in Q1 2025. Operating income hit -$21.56M last quarter, sustaining a consistent -13% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$18.81M. Net income rose to -$17.19M, while earnings per share reached -$0.17. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan